Eyal Epstein

Years Active: 2022-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Einat Toister, Lilach Cherry, Edith Lupu, Arik Monash, Eyal Dor, Lilach Levin, Meni Girshengorn, Niva Natan, Shira Chapman, Shlomo Shmaya, Eyal Epstein, Yaakov Adar, Ran Zichel, Yakir Ophir, Eran Diamant
Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2. Vaccines 12 (4) (2024)
Einat Toister, Lilach Cherry, Edith Lupu, Arik Monash, Eyal Dor, Lilach Levin, Meni Girshengorn, Niva Natan, Shira Chapman, Shlomo Shmaya, Eyal Epstein, Yaakov Adar, Ran Zichel, Yakir Ophir, Eran Diamant
Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2. Vaccines 12 (4) (2024)
Adva Mechaly, Eran Diamant, Ron Alkalay, Alon Ben David, Eyal Dor, Amram Torgeman, Ada Barnea, Meni Girshengorn, Lilach Levin, Eyal Epstein, Ariel Tennenhouse, Sarel Jacob Fleishman, Ran Zichel, Ohad Mazor
Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope. Antibodies (Basel, Switzerland) 11 (1) (2022)

Eyal Epstein.css-eqlu8i{font-size:small;padding-left:4px;}